Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Short-term Investments (2016 - 2025)

Pediatrix Medical (MD) has disclosed Short-term Investments for 17 consecutive years, with $124.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 4.99% to $124.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $124.5 million, a 4.99% increase, with the full-year FY2025 number at $124.5 million, up 4.99% from a year prior.
  • Short-term Investments was $124.5 million for Q4 2025 at Pediatrix Medical, up from $123.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $124.5 million in Q4 2025 to a low of $89.6 million in Q1 2022.
  • A 5-year average of $105.9 million and a median of $102.2 million in 2021 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: rose 20.76% in 2021, then fell 11.14% in 2022.
  • Pediatrix Medical's Short-term Investments stood at $99.7 million in 2021, then dropped by 6.49% to $93.2 million in 2022, then grew by 12.06% to $104.5 million in 2023, then rose by 13.48% to $118.6 million in 2024, then increased by 4.99% to $124.5 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Short-term Investments are $124.5 million (Q4 2025), $123.0 million (Q3 2025), and $123.6 million (Q2 2025).